International Journal of General Medicine · 2019 · 16 citations · 16 references
Life SciencesMolecular BiologyNeurologyGene ExpressionGene Expression AnalysisMolecular DiagnosticsAcute Ischemic StrokeCerebrovascular DiseaseMicrorna BiologyStrokeCirculating MicrornasMatched Control GroupMicrorna BiomarkersMicrorna Expression ProfilingPrimary Outcome AnalysisQuantitative Pcr DetectionReal-time Polymerase Chain Reaction (Pcr)Stroke Biomarkers
Aim: We conducted the present prospective study to assess the level of microRNA (miRNA) 146a in patients with ischemic stroke and its correlation with patients’ characteristics. Methods: We conducted an observational study that included adult patients (≥18 years old) who presented within 24 hrs after the onset of the symptoms of acute ischemic stroke. In addition, age- and sex-matched healthy volunteers were included as control group. The primary outcome in the present study was the difference in miRNA 146a expression between patients with ischemic stroke and control group participants. The expression of miRNA 146a was measured using quantitativereal-time PCR. Quantitativereal-time PCR amplification and analysis were performed using Rotor-Gene Q thermal cycler. Results: The present study included 44 patients with ischemic stroke and 22 matched controls. Regarding the primary outcome of the present study, the median expression of miRNA 146a in patients with ischemic stroke was −1.98 fold (IQR −27.1–3.9) compared to 1.75 fold (IQR −2.25–5.27) in control group ( P <0.001). However, the subgroup analysis showed that the expression of miRNA 146a was significantly downregulated in comatosed patients only ( P <0.001). The expression of miRNA 146a correlated negatively with Glasgow Coma Scale score in comatose patients ( r =−0.352, P =0.022). Conclusion: In conclusion, the expression of miRNA 146a is significantly downregulated in ischemic stroke patients. Further studies are needed to assess its diagnostic utility and therapeutic potentials. Keywords: ischemic stroke, coma, cerebral infarction, miRNA 146a
16
Erik von Elm, Douglas G. Altman, Matthias Egger et al. · PLoS Medicine · 2007 · 21.6K citations · Full text
Public Health, Public Health Practice, Epidemiologic Methods +10
ASSESSMENT OF COMA AND IMPAIRED CONSCIOUSNESS
Graham M. Teasdale, Bryan Jennett · The Lancet · 1974 · 13.1K citations
Erik von Elm, Douglas G. Altman, Matthias Egger et al. · International Journal of Surgery · 2014 · 9.9K citations · Full text
Public Health, Public Health Practice, Epidemiologic Methods +10
An Updated Definition of Stroke for the 21st Century
Ralph L. Sacco, Scott E. Kasner, Joseph P. Broderick et al. · Stroke · 2013 · 3.5K citations · Full text
Medicine, Neurology, Neuroscience +11
MicroRNA-146a: A Key Regulator of Astrocyte-Mediated Inflammatory Response
Anand M. Iyer, Emanuele Zurolo, Avanita S. Prabowo et al. · PLoS ONE · 2012 · 324 citations · Full text